Phase I Study of HRS-3005 in B-cell Malignancies

Clinical trial NCT07556822 · RECRUITING

Trial details

NCT number: NCT07556822
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Malignancy

Start date: 2026-06-03
Primary completion: 2028-10-01
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.